A systematic review and meta-analysis compares survival outcomes with whole-pelvic vs prostate-only radiotherapy in men with clinically node-negative high-risk localized prostate cancer.
The time of day at which patients with advanced cancer receive immune checkpoint inhibitors may be far more consequential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results